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RAB43 facilitates cross-presentation of cell-associated
antigens by CD8α+ dendritic cells
Nicole M. Kretzer,1* Derek J. Theisen,1* Roxane Tussiwand,1,3 Carlos G. Briseño,1
Gary E. Grajales‑Reyes,1 Xiaodi Wu,1 Vivek Durai,1 Jörn Albring,4 Prachi Bagadia,1 Theresa L. Murphy,1
and Kenneth M. Murphy1,2
1

Department of Pathology and Immunology and 2Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, MO 63110
Department of Biomedicine, University of Basel, 4003 Basel, Switzerland
4
Department of Medicine A, Hematology and Oncology, University of Münster, Münster 48149, Germany

I n this study, to examine cross-presentation by classical dendritic cells (DCs; cDCs), we evaluated the role of RAB43, a protein
found to be selectively expressed by Batf3-dependent CD8α+ and CD103+ compared with other DC subsets and immune lineages. Using a specific monoclonal antibody, we localized RAB43 expression to the Golgi apparatus and LAMP1− cytoplasmic
vesicles. Mice with germline or conditional deletion of Rab43 are viable and fertile and have normal development of cDCs but
show a defect for in vivo and in vitro cross-presentation of cell-associated antigen. This defect is specific to cDCs, as Rab43deficient monocyte-derived DCs showed no defect in cross-presentation of cell-associated antigen. These results suggest that
RAB43 provides a specialized activity used in cross-presentation selectively by CD8α+ DCs but not other antigen-presenting
cells.
Introduction
In cross-presentation, exogenous antigens taken up by
APCs are processed for presentation by MHCI (Bevan,
1976; Ackerman and Cresswell, 2004; Rock and Shen,
2005). In vivo, cross-presentation of cell-associated antigen has been attributed primarily to a subset of splenic
DCs identified by expression of CD8α (den Haan
et al., 2000). The dominant role of CD8α+ DCs in
cross-presentation appears not to result from more efficient antigen capture but, rather, specialized pathways
of processing that are active in CD8α+ DCs but not in
CD8α− DCs (Schnorrer et al.,2006).CD8α+ DCs express cellsurface receptors, such as CLEC9A (Poulin et al., 2012),
that can deliver antigens to cross-presentation pathways
(Schulz and Reis e Sousa, 2002). Additionally, DC lysosomes have decreased protease activity, compared with
macrophages, which improves antigen presentation and
persistence in lymphoid organs (Delamarre et al., 2005).
RAB27A (Jancic et al., 2007) and RAC2 (Savina et al.,
2009) have been linked to this process through recruitment of NOX2 to phagosomes, which delays their acidification by producing reactive oxygen species that consume
protons generated by V-ATPase in phagosomal membranes (Savina et al., 2006).
*N.M. Kretzer and D.J. Theisen contributed equally to this paper.
Correspondence to Kenneth M. Murphy: kmurphy@wustl.edu
Abbreviations used: cDC, classical DC; CDP, common DC progenitor; DPBS, Dulbecco’s
PBS; HKLM-OVA, heat-killed Listeria monocytogenes expressing OVA; MACS,
magnetic-activated cell sorting; moDC, monocyte-derived DC; pDC, plasmacytoid
DC; polyI:C, polyinosinic:polycytidylic acid; sLN, skin-draining LN; STAg, soluble
tachyzoite antigen.
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Peptides derived from exogenous proteins can be loaded
onto MHCI either in the ER or in endocytic compartments
where components of the peptide-loading complex have
been recruited (Cebrian et al., 2011). Cross-presentation
may involve movement of antigens from endosomes through
transporters such as SEC61 into the cytosol where they are
degraded (Zehner et al., 2015). Alternatively, cross-presentation may involve a strictly vacuolar pathway in which antigens are digested by cathepsins within vesicles (Shen et al.,
2004) and directly loaded onto MHCI molecules that are
present in the same compartment (Guermonprez et al., 2003).
This pathway may be facilitated by the fusion of phagosomes
with the ER–Golgi intermediate complex, a process enabled
by SEC22B (Cebrian et al., 2011).
Much of the work done to identify these crosspresentation pathways has relied on in vitro generated
monocyte-derived DCs (moDCs) and, therefore, not described pathways that are unique to CD8α+ DCs in vivo
(Cebrian et al., 2011; Nair-Gupta et al., 2014; Zehner et
al., 2015). We identified RAB43 as a small GTPase that is
specifically expressed in CD8α+ DCs and is necessary for
optimal cross-presentation of cell-associated and soluble antigens by CD8α+ classical DCs (cDCs) but not moDCs. We
show that RAB43 is localized to the Golgi and cytoplasmic
vesicles distinct from lysosomes and that it is not essential for
normal Golgi development, in contrast to previous suggestions (Haas et al., 2007).
© 2016 Kretzer et al. This article is distributed under the terms of an Attribution–Noncommercial–Share
Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org
/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–
Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).

Supplemental Material can be found at:
/content/suppl/2016/11/28/jem.20160597.DC1.html

2871

Downloaded from on January 31, 2017

The Journal of Experimental Medicine

3

Published November 29, 2016

Rab43-deficient mice are viable
and have normal cDC development
RAB43 has only been examined by overexpression or shRNA-mediated knockdown in transformed cell lines in vitro
(Haas et al., 2005, 2007; Fuchs et al., 2007). A potential
dominant-negative RAB43 (T32N) mutation reportedly induced Golgi fragmentation in HeLa cells (Haas et al., 2007),
suggesting that RAB43 may function in Golgi development
or maintenance. However, these conclusions were based on
in vitro morphological analysis of HeLa and hTERT-RPE1
cells, in which endogenous levels of RAB43 protein were
not determined. No studies have yet analyzed the in vivo
role of RAB43 or its function in CD8α+ DCs where it
is most highly expressed.
To test the in vivo role of RAB43, we generated Rab43f/f mice that allow conditional deletion of the Rab43 exon
2, which encodes critical residues of the Rab domain (Fig.
S2). Conditional deletion in cDCs was achieved by crossing to
CD11c (Itgax)-Cre (Caton et al., 2007) to produce Rab43cKO
mice, and constitutive germline Rab43 deletion (Rab43Δ/Δ)
was achieved on 129SvEv and C57BL/6 backgrounds by
crossing to germline-expressing Cre-deleter strains.
Rab43Δ/Δ and Rab43cKO mice were viable and produced
fertile offspring at normal Mendelian frequencies.To confirm
that RAB43 protein was absent from DCs in Rab43Δ/Δ and
Rab43cKO mice, we performed Western analysis for RAB43
using 2E6 on CD11c− or CD11c+ splenocytes (Fig. 1 F). In
2872

WT mice, RAB43 protein was detected in CD11c+ splenocytes but not in CD11c− splenocytes (Fig. 1 F), as expected.
In Rab43Δ/Δ mice, RAB43 was not detectable in either
CD11c+ splenocytes or CD11c− splenocytes, indicating that
germline deletion of Rab43 exon 2 is sufficient to eliminate
RAB43 protein (Fig. 1 F). In Rab43f/f mice, RAB43 was detectable in CD11c+ splenocytes as expected, but RAB43 was
nearly undetectable in Rab43cKO mice (Fig. 1 G). This result
indicates that exon 2 deletion by CD11c-Cre can efficiently
eliminate RAB43 protein in cDCs.
Loss of RAB43 in Rab43Δ/Δ mice caused no changes
in the development of mature B cells, CD4+ T cells, CD8+
T cells, BM monocytes, or pDCs (not depicted). Furthermore,
there was no impact on DC development in Rab43Δ/Δ
mice, which showed normal populations of splenic cDCs
(Fig. 1 H) and normal migratory and resident DCs in sLNs
(Fig. 1 I). Populations of DCs were normal in nonlymphoid
tissues such as the liver and small intestine lamina propria
(Fig. 1 J). RAB43-deficient DCs also produced normal levels
of cytokines upon stimulation by LPS, CpG, polyinosinic
:polycytidylic acid (polyI:C), and soluble tachyzoite antigen
(STAg; Fig. 1 K). Thus, RAB43 is selectively expressed in
CD8α+ cDCs but is not required for their development
or response to stimuli.
RAB43 is localized to the Golgi
and LAMP1− vesicles in CD8α+ DCs
To determine the localization of RAB43 within DCs, we
performed immunofluorescence microscopy on FLT3Lcultured BM cells using 2E6 antibody along with markers of various organelles (Fig. 2). RAB43 was expressed in
brightly staining perinuclear organelles that colocalized with
giantin, a cis-Golgi marker (Fig. 2, A and E). 2E6 staining
was specific for RAB43 because no 2E6 signal was seen in
Rab43Δ/Δ DCs (Fig. 2 A, bottom). RAB43 did not colocalize
with the ER marker calnexin, (Fig. 2, B and E) and showed
only limited colocalization with the trans-Golgi marker
TGN38 (Fig. 2, C and E).
Specific RAB43 staining was also evident in small cytoplasmic vesicles throughout the DCs’ long dendritic branches
(Fig. 2 F). No vesicular staining was seen in Rab43Δ/Δ DCs
(Fig. 2 A). 2E6 staining did not colocalize with LAMP1, suggesting that the RAB43-expressing vesicles are not lysosomes
(Fig. 2, D and E). In summary, RAB43 appears to be expressed
on cis-Golgi and in a nonlysosomal vesicular compartment.
RAB43-deficient CD8α+ DCs have an intact Golgi apparatus
Because RAB43 was suggested to control Golgi integrity in
HeLa cells (Haas et al., 2007), we asked whether the Golgi
was intact in DCs isolated from WT and Rab43Δ/Δ mice
(Fig. 3, A and B). RAB43 colocalized with giantin in CD8α+
cDCs freshly isolated from WT mice (Fig. 3 A), in agreement
with analysis of in vitro generated cDCs (Fig. 2). Freshly isolated CD8α− cDCs were negative for 2E6 staining (Fig. 3 A),
consistent with RAB43 expression assessed by Western analRAB43 facilitates cross-presentation | Kretzer et al.
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Results and discussion
Rab43 is highly expressed in CD8α+ DCs
We evaluated expression of all RAB family members present in mouse genome 430 2.0 microarrays (Satpathy et al.,
2012; Kc et al., 2014) for expression in CD8α+ DCs, CD8α−
DCs, and common DC progenitors (CDPs; Fig. 1 A; Naik
et al., 2007). Rab43 was among the most highly expressed
RAB proteins in CD8α+ DCs compared with CDPs and
CD8α− DCs. Mouse and human RAB43 are 95% identical
(Fig. S1), suggesting evolutionary conservation. Using RTPCR, we directly confirmed that Rab43 was most highly
expressed in CD8α+ DCs compared with CD8α− DCs,
plasmacytoid DCs (pDCs), monocytes, T cells, and B cells
(Fig. 1 B). In the skin-draining LN (sLN), CD8α+ resident
and CD103+ migratory DCs express the highest levels of
Rab43 (Fig. 1 C; Heng et al., 2008).
To analyze RAB43 at the protein level, we generated
a monoclonal antibody, 2E6, directed to amino acids 179–
203, a region of RAB43 that is highly divergent from other
RAB family members. Using 2E6 for Western analysis, we
confirmed that RAB43 protein was specifically expressed in
CD8α+ cDCs at levels that were substantially higher than in
CD8α− DCs, pDCs, monocytes,T cells, and B cells (Fig. 1 D).
Intracellular staining with biotinylated 2E6 also showed that
RAB43 is most abundant in CD8α+ resident and CD103+
migratory DCs in the sLN compared with other DC subsets,
similar to what is observed in the spleen (Fig. 1 E).
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Figure 1. Rab43is highly and selectively expressed in CD8α+ cDCs and does not impact cDC development. (A) Sorted WT CD8α+ DCs, CD8α− DCs,
and BM CDPs analyzed by gene expression microarray. Expression levels were determined for a list of Rab proteins in mouse 430 2.0 and plotted based on
CD8α+ DC/CDP (x axis) versus CD8α+ DC/CD8α− DC (y axis) expression ratios. Each dot indicates an individual probe set. Data are representative of at least
two independent experiments with three pooled mice. (B) Expression value (in arbitrary units) of Rab43 mRNA normalized to Hprt by quantitative RT-PCR
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RAB43-deficient CD8α+ cDCs have reduced crosspresentation both in vitro and in vivo
Because trafficking of intracellular vesicular compartments is
necessary for antigen cross-presentation and CD8α+ DCs are

efficient for this activity (den Haan et al., 2000; Iyoda et al.,
2002; Schnorrer et al., 2006; Hildner et al., 2008), we asked
whether RAB43 might have a role in antigen presentation by
DCs. CD8α+ DCs and CD8α− DCs purified from WT and
Rab43Δ/Δ mice were tested for their ability to cross-present
HKLM-OVA to OT-1 T cells in vitro (Fig. 4, A and B). WT
CD8α+ DCs cross-presented HKLM-OVA in a dose-dependent manner; however, CD8α+ DCs from Rab43Δ/Δ mice
induced significantly less OT-1 proliferation at both low
and high doses of bacteria (Fig. 4 A). Cross-presentation of
HKLM-OVA by CD8α− DCs from WT or Rab43Δ/Δ mice
was not observed at any dose tested (Fig. 4 B).
OT-1 T cells also proliferated in response to soluble
antigen presented by WT CD8α+ DCs in a dose-dependent
manner (Fig. 4 C). Using CD8α+ DCs from Rab43Δ/Δ mice,
OT-1 proliferation was significantly reduced at intermediate
doses of soluble OVA but not at the maximal dose (Fig. 4 C).
CD8α− DCs were able to cross-present soluble OVA, but this
required a higher concentration than that needed for OT-1
stimulation by CD8α+ DCs, and there was no difference between WT and Rab43Δ/Δ DCs (Fig. 4 D).These results suggest
that CD8α+ DCs have a unique cross-presentation program
that is Rab43 dependent.This pathway is involved in the presentation of cell-associated but less so soluble antigens and
may not be necessary for presentation of high soluble antigen
loads. As a control, presentation of SIINFEKL peptide was
equal between CD8α+ DCs and CD8α− cDCs from either
WT or Rab43Δ/Δ mice, suggesting MHCI levels are normal
on Rab43Δ/Δ DCs (Fig. 4 E).
We next tested the ability of Rab43cKO mice to prime
T cells in vivo using cell-associated antigen (Carbone and
Bevan, 1990). The number of active (CD44+CD62L−) Kb SII
NFEKL tetramer-positive T cells in the spleen was analyzed 8 d
after injection of irradiated MHCI TKO (Kb−/−Db−/−β2m−/−)
splenocytes loaded with OVA or PBS. We found that Rab43cKO mice had a reduced ability to prime CD8 T cells against
cell-associated antigen in vivo (Fig. 4 F).
The defect in T cell priming was specific to crosspresentation because direct presentation of intracellu-

for the indicated cell populations. Data from three independently sorted replicates of three WT mice displayed as mean ± SEM are shown. (C) Immgen data
showing expression of Rab43 in the indicated populations from sLN. Data are displayed as mean ± SEM with three measurements per sample. (D) Western
analysis of RAB43 and β-actin for the indicated spleen or BM populations from WT mice. Data are representative of at least three independent experiments.
Mac, macrophage; Mono, monocyte. (E) Intracellular staining for RAB43 in the indicated cells from spleen and sLN from WT and Rab43Δ/Δ B6 mice. The
numbers represent the mean fluorescence intensity of RAB43 staining for the indicated cells. Data are representative of two independent experiments.
(F) Western analysis for RAB43 and lamin B from WT or Rab43Δ/Δ 129 (Δ/Δ) splenocytes. CD11c-negative (−) or CD11c-positive (+) splenocytes were isolated using CD11c microbeads. Data are representative of at least two experiments. (G) Western analysis for RAB43 and lamin B from CD11c-negative (−)
or CD11c-positive (+) B6 splenocytes isolated as in A derived from Rab43f/f mice that were either CD11cCre− (Cre-) or CD11cCre+ (Cre+) as indicated. Data
are representative of at least two experiments. (D, F, and G) Scales indicate molecular weight in kD. (H) Percentage (left) and absolute number (right) of
DC subpopulations from spleen of WT and Rab43Δ/Δ B6 mice. (I) Percentage (left) and absolute number (right) of DC subpopulations from sLN of WT and
Rab43Δ/Δ mice. Cells gated based on resident (B220−MHCIIintCD11chi) and migratory (B220−MHCIIhiCD11cint/lo) populations are shown. (H and I) Data from
three independent experiments are shown. Each dot represents a single mouse. (J) Contour plots of tissue DCs from the small intestine lamina propria
(SILP) or liver of WT or Rab43Δ/Δ 129 mice pregated on B220−CD45.2+MHCII+CD11c+. Data are representative of at least two experiments. (K) Percentage of
IL-12– and TNF-positive cells after incubation of FLT3L-cultured BM cells from WT and Rab43Δ/Δ 129 mice with LPS, CpG, polyI:C, or STAg. Data from two
independent experiments displayed as mean ± SEM are shown.
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ysis (Fig. 1 D) and intracellular staining (Fig. 1 E). The area
of giantin staining is similar in both WT and Rab43Δ/Δ DCs,
suggesting that the absence of RAB43 protein had no apparent impact on its distribution (Fig. 3 C).
Furthermore, we used electron microscopy to examine CD8α+ DCs purified from Rab43f/f and Rab43cKO mice.
There were no notable differences in morphology or density
of Golgi membranes (Fig. 3, D and E). Glycoprotein analysis
of LAMP1 shows that Golgi-mediated glycosylation is normal
in Rab43Δ/Δ DCs (Fig. 3 F). It has also been shown that overexpression of RN-tre, a possible GTPase-activating protein
for RAB43 (Fuchs et al., 2007), does not alter ER to Golgi
transport of vesicular stomatitis virus G in HeLa cells (Haas
et al., 2007). Therefore, RAB43 appears to be dispensable for
development and function of the Golgi apparatus in cDCs.
To analyze the localization of RAB43 after antigen uptake, we incubated in vitro Flt3L-derived DCs with heat-killed
Listeria monocytogenes expressing OVA (HKLM-OVA). We
found that RAB43 still localizes to the Golgi after uptake of
antigen and also that HKLM-OVA localized to a perinuclear
region near the Golgi apparatus in both WT and Rab43Δ/Δ
DCs (Fig. 3, G and H; and Videos 1 and 2).Therefore, RAB43
localization is not dependent on the uptake of antigen.
A previous study has suggested that RAB43 is involved
in the recruitment of cathepsin D to phagosomes (Seto et
al., 2011). Because cathepsin D has been implicated in crosspresentation in human moDCs (Fonteneau et al., 2003), we
examined whether the mechanism of RAB43 action could
involve regulation of cathepsin D. We found that cathepsin D was not expressed in either cDC population at either
the transcript or protein level and that this did not change
upon activation by LPS (Fig. 3, I and J). This suggests that
the mechanism of action of RAB43 in CD8α+ DCs does not
involve the regulation of cathepsin D.

Published November 29, 2016
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Figure 2. RAB43 is abundant in Golgi and vesicles of Batf3-dependent DCs. (A) Day 10 FLT3L-cultured BM from WT (top) or Rab43Δ/Δ (bottom) 129
mice was treated with LPS for 4 h (to improve attachment), allowed to attach to coverslips, fixed, stained with 2E6 (anti-RAB43; green) and anti-giantin
(red), and attached to slides using Prolong Gold antifade with DAPI (blue). (B–D) WT cells as described in A untreated with LPS were stained with 2E6 (green)
and anti-calnexin (red; B), anti-TGN38 (red; C), or anti-LAMP1 (red; D). Coverslips were attached to slides using Prolong Gold antifade with DAPI (blue).
(E) Percentage of organelle stain that is colocalized with RAB43 stain for the indicated organelles. Each dot represents a single cell with 10–23 cells analyzed
per stain. Data were obtained using Imaris Coloc2. Statistics were analyzed using ANOVA. *, P < 0.05; ****, P < 0.0001. (F) WT cells prepared as described
in A shown at increased zoom to highlight vesicular staining. All microscopy data are representative of at least two independent experiments. Bars, 5 µm.
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Figure 3. Rab43Δ/ΔCD8α+ DCs have normal Golgi development. (A and B) Sorted Ly6G−Ly6C−Thy1.2−B220−DX5−F4/80−CD11c+ splenocytes from WT (A)
or Rab43Δ/Δ (Δ/Δ; B) 129 mice were allowed to attach to coverslips, fixed, and stained for CD8α (white), giantin (red), and RAB43 (green). Coverslips were
attached to slides using ProLong Gold antifade with DAPI (blue). Data are representative of at least three independent experiments. Bars, 5 µm. (C) Area of
Golgi staining from WT and Rab43Δ/Δ DCs. Each dot represents a single cell from staining in A and B, with 15 cells analyzed per genotype. Area was obtained
using ImageJ. Statistics were analyzed by a two-tailed Mann-Whitney U test with P > 0.5. (D and E) Electron microscopy of sorted B220−CD11c+MHCII+CD24+CD172a− splenocytes from Rab43f/f-CD11cCre− (D) or Rab43f/f-CD11cCre+ (E) B6 mice showing normal Golgi development. Data are from analysis of cells
from five pooled mice. Bars, 500 nm. (F) Western analysis for LAMP1 in splenocyte protein lysate given no treatment (No Tx), EndoH, or PNGaseF. Data are
representative of three independent experiments. The scale indicates molecular weight in kD. (G and H) Sorted SiglecH−CD11b−Sirpa−Bst2− cells from FLT3
cultures of WT (G) or Rab43Δ/Δ (H) B6 BM were incubated with Alexa Fluor 647–labeled HKLM-OVA (white) and then prepared as in B without CD8α stain
(Videos 1 and 2). The yellow arrowhead indicates a RAB43-deficient DC that has taken up HKLM-OVA. Images are representative of three experiments. Bars,
5 µm. (I) Immgen expression data for cathepsin D in red pulp macrophages (RP MF), CD8α+ DCs, and CD8α− DCs, displayed as mean ± SEM with three to
four measurements per cell type. (J) Western analysis for cathepsin D (top) and β-actin (bottom) in BM macrophages (BMM), CD8α+ DCs, and CD8α− DCs
from Flt3L or M-CSF cultures either treated or untreated with LPS for 24 h. The scale indicates molecular weight in kD.
2876
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lar OVA and MHC
II presentation were not affected in
Rab43Δ/Δ mice (Fig. 4, G and H). In summary, RAB43
functions in a cross-presentation–specific pathway that is involved in the presentation of cell-associated and low-dose
soluble antigen by CD8α+ DCs.

JEM Vol. 213, No. 13

from one mouse. (G) Sorted CD8α+ (solid) or CD8α− (dashed) DCs from WT
(black) or Rab43Δ/Δ (red) mice were osmotically loaded with OVA, cultured,
and analyzed as in A. (H) Sorted CD8α+ (solid) or CD8α− (dashed) DCs from
WT (black) or Rab43Δ/Δ (red) mice were cultured for 3 d with CFSE-labeled
OT-II T cells and irradiated splenocytes osmotically loaded with OVA. T cells
were assayed for proliferation and activation (CFSE−CD44+). All data are
displayed as mean ± SEM from at least two independent experiments. Statistics were analyzed using two-way ANOVA. ***, P < 0.001; ****, P < 0.0001.
2877
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Figure 4. CD8α+ DCs from Rab43Δ/Δ mice are defective in cross-presentation of cell-associated and soluble antigens. (A and B) Sorted
CD8α+ (A) or CD8α− (B) DCs from WT (black) or Rab43Δ/Δ (red) B6 mice were
cultured for 3 d with CFSE-labeled OT-I T cells and different doses of HKLMOVA and assayed for OT-I proliferation and activation (CFSE−CD44+). (C and
D) Sorted CD8α+ (C) or CD8α− (D) DCs from WT (black) or Rab43Δ/Δ (red)
mice were cultured and analyzed as in A with various doses of soluble OVA
as antigen. (E) Sorted CD8α+ (continuous lines) or CD8α− (dashed lines) DCs
from WT (black) or Rab43Δ/Δ (red) mice were cultured and analyzed as in
A with the indicated amounts of SIINFEKL peptide as antigen. (F) Rab43f/fCD11cCre− (black) or Rab43f/f-CD11cCre+ (red) mice were injected with the indicated numbers of PBS (OVA−)- or OVA (OVA+)-loaded irradiated MHCI TKO
splenocytes and analyzed 8 d later for the number of Kb SIINFEKL tetramer+
(tet+) T cells that were CD44+CD62L−. Each dot represents cells obtained

moDCs from RAB43-deficient mice show no
defect in cross-presentation
moDCs generated with GM-CSF and IL-4 can crosspresent cell-associated antigen to a similar efficiency as CD8α+
DCs but use a distinct transcriptional program to acquire
this capacity (Briseño et al., 2016). We asked whether crosspresentation by moDCs is Rab43 dependent (Fig. 5).Western
analysis using 2E6 showed that RAB43 is expressed at a low
level in moDCs generated with GM-CSF only (moDC GM)
or with GM-CSF and IL-4 (moDC GM/4; Fig. 5 A). OT-1
priming by Rab43Δ/Δ moDC GM/4 was equal to that of
WT moDC GM/4 at all antigen doses for both presentation of OVA-loaded irradiated splenocytes and HKLM-OVA
(Fig. 5, B and C). Thus, cross-presentation by moDCs uses
a Rab43-independent pathway distinct from the Rab43dependent pathway in CD8α+ DCs. Similarly, crosspresentation of soluble OVA by moDCs and cDCs can occur
through distinct pathways (Segura et al., 2009).
Several in vitro studies have relied on moDCs cells to
analyze cross-presentation (Cheong et al., 2010; Cebrian et
al., 2011; Nair-Gupta et al., 2014; Zehner et al., 2015), even
though in vivo cross-presentation appears specific to CD8α+
DCs (Iyoda et al., 2002; Schulz and Reis e Sousa, 2002;
Sancho et al., 2009). Based on our data, moDCs may not be
appropriate in vitro models for cross-presentation, and molecules analyzed using moDCs should be confirmed using
primary CD8α+ DCs obtained from animal models.
In conclusion, RAB43 functions in a CD8α+ DC–
specific pathway necessary for efficient cross-presentation of
cell-associated antigen. Our data suggest that there are two
separate pathways for soluble antigen presentation, and lowdose presentation was seen only in CD8α+ DCs and was dependent on RAB43. These results suggest that the form and
amount of internalized antigen may impact how it is eventually processed and presented in CD8α+ DCs. This could
be caused by differential endocytosis (i.e., receptor mediated
versus micropinocytosis) or alternative methods of processing
soluble proteins versus intact cells. The Golgi and vesicular
localization of RAB43 suggests it may function in intracellu-
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Figure 5. moDCs from Rab43Δ/Δ mice show no defect in
cross-presentation. (A) Western analysis of RAB43 and β-actin
in CD8α+ and CD8α− cDCs compared with moDCs cultured for 4
d with either GM-CSF alone (GM) or GM-CSF + IL-4 (GM/4). Data
are representative of at least two experiments. The scale indicates
molecular weight in kD. (B) GM-CSF + IL-4–cultured moDCs from
WT (black) or Rab43Δ/Δ (red) 129 monocytes were cultured with
the indicated numbers of PBS (OVA−)- or OVA (OVA+)-loaded irradiated MHCI TKO splenocytes and OT-I T cells. After 3 d, cultures
were assayed for OT-I proliferation and activation (CFSE−CD44+).
(C) Sorted CD8α+ and CD8α− DCs and in vitro generated moDC
GM-CSF + IL-4 from WT (black) or Rab43Δ/Δ (red) B6 mice were
cultured for 3 d with CFSE-labeled OT-I T cells and different doses
of HKLM-OVA and assayed for OT-I proliferation and activation
(CFSE−CD44+). Cross-presentation data are displayed as mean ±
SEM from at least three independent experiments.

Materials and methods
Mice
WT 129SvEv mice were purchased from Taconic. WT
C57BL/6,
B6.SJL-PtprcaPepcb/BoyJ
(B6.SJL),
and
C57BL/6-Tg(TcraTcrb)1100Mjb/J (OT-1) mice were purchased from The Jackson Laboratory. Mice designated as
WT were from in-house breeding of C57BL/6 or 129SvEv
strains. Experiments done with Rab43f/f mice used littermate
controls. MHCI KO mice (Kb−/−Db−/−β2m−/−; TKO) were
a gift from H.W. Virgin and T. Hansen (Washington University, St. Louis, MO; Lybarger et al., 2003). Experiments were
performed with age- and sex-matched mice between 6 and
12 wk of age. All mice were bred and maintained in specific
pathogen–free facilities according to institutional guideline
protocols approved by the Animal Studies Committee of
Washington University in St. Louis.
Generation of the Rab43cKO mouse
The Rab43f/f-targeting construct was generated using Gateway
recombination (Invitrogen) as follows.The entry vector, pENTRlox-FRT-rNeo, was created by replacing the puromycin resistance
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gene in pENTR-lox-Puro (Iiizumi et al., 2006) with the neomycin resistance gene from vector pLNTK, and frt sites flanking each
loxP site were added.The Rab43 5′ homology arm was amplified
by PCR from 129SvEv-EDJ22 embryonic stem cell (ES cell)
genomic DNA using oligonucleotides containing attB4 and attB1
sites, 5′-GGGGACAACTTTGTATAGAAAAGTTGGCAG
ACCTCCTACTCCAAAG-3′ and 5′-GGGGACTGCTTT
TTTGTACAAACTTGCAAGGCTGCACTGAGGCTA-3′.
The attB4-attB1 PCR fragment was inserted into the pDONR
(P4-P1R) plasmid (Invitrogen) by the bp recombination reaction generating pENTR-RAB43-5HA. The Rab43 3′ homology arm was amplified by PCR from genomic DNA using the
following oligonucleotides containing attB2 and attB3 sites:
5′-GGGGACAGCTTTCTTGTACAAAGTGGGAGCCAA
TTCCTTACCTCCA-3′ and 5′-GGGGACAACTTTGTA
TAATAAAGTTGTAGAAGGGACGGATGCAGC-3′. The
attB2-attB3 PCR fragment was inserted into pDONR(P2R-P3)
plasmid (Invitrogen) by the bp recombination reaction generating
pENTR-RAB43-3HA. pENTR-RAB43-3HA was digested
with Acc1 to produce an overhang where an overlapping oligonucleotide containing an orphan loxP site could anneal. The
annealed oligonucleotides for insertion of the orphan loxP site
were as follows: 5′-CTATAACTTCGTATAGCATACATTATA
CGAAGTTATGGATCC-3′ and 5′-AGGGATCCATAACTT
CGTATAATGTATGCTATACGAAGTTAT-3′. After ligation,
sequencing confirmed the insertion of the orphan loxP, and the
resulting plasmid was called pENTRE-RAB43-3HA-Acc1. LR
recombination reaction was performed using pENTR-RAB435HA, pENTR-RAB43-3HA-Acc1, pENTR-lox-FRT-rNeo,
and pDEST-DTA-MLS to generate the final targeting construct.
RAB43 facilitates cross-presentation | Kretzer et al.
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lar transport of antigen or the peptide-loading complex. Our
data show that moDCs cross-present through mechanisms
distinct from those used by CD8α+ DCs in vivo, suggesting that previous mechanisms proposed for cross-presentation
that relied on moDCs may need to be reevaluated in the
correct cell type. These studies will provide useful insight
for designing vaccines that more selectively target efficient
cross-presentation pathways.
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Antibodies and flow cytometry
Flow cytometry and cell-sorting experiments were completed on a FACS CantoII, FACSAriaII, or FACSAria Fusion
instrument (BD) and analyzed using FlowJo analysis software
(Tree Star). Staining was performed at 4°C in the presence of
Fc block (clone 2.4G2; BD) in magnetic-activated cell-sorting (MACS) buffer (Dulbecco’s PBS [DPBS] + 0.5% BSA
+ 2 mm EDTA).The following antibodies were purchased
from BD: anti-CD3 (145-2C11), anti-CD8 (53-6.7), anti-CD11c (HL3), anti-CD19 (1D3), anti-B220 (RA3-6B2),
anti-CD172a (P84), anti-Ly6C (AL-21), anti-Ly6G (1A8),
and anti–H-2Kb (AF6-88.5). The following antibodies were
purchased from BioLegend: anti-CD4 (RM4-5), anti-CD11c
(N418), anti-CD24 (M1/69), anti-CD115 (AFS98), anII (I-A/I-E; M5/114.15.2),
ti-CD135 (A2F10), anti-MHC
and anti–TCR-Vα2 (B20.1). The following antibodies
were purchased from eBioscience: anti-CD44 (IM7), anti-CD45.2 (104), anti-CD90.2 (53-2.1), anti-CD103 (2E7),
anti-CD117 (2B8), anti-CD317 (eBio927), anti-F4/80
(BM8), anti-TER119 (TER-119), anti-CD62L (MEL14), and anti-SiglecH (eBio440c). The following antibodies were purchased from Tonbo Biosciences: anti-CD11b
(M1/70) and anti-CD45.1 (A20).
JEM Vol. 213, No. 13

For immunofluorescence and confocal microscopy,
the following antibodies were purchased from Abcam: rabbit polyclonal anti-giantin (ab24586) and rabbit polyclonal
anti-calnexin (ab22595). The following antibody was purchased from Santa Cruz Biotechnology, Inc.: rabbit polyclonal anti-TGN38 (sc-33784). The following antibodies
were purchased from Invitrogen: Alexa Fluor 488 goat anti–
mouse IgG (H + L), Alexa Fluor 488 goat anti–rabbit IgG
(H + L), Alexa Fluor 647 goat anti–rabbit IgG (H + L), and
streptavidin, Alexa Fluor 555 conjugate.
For Western analysis, the following antibodies were purchased from Santa Cruz Biotechnology,Inc.:anti–β-actin (C4) and
anti–lamin B (M-20). Anti-Lamp1 (ab24170) was from Abcam.
Anti–cathepsin D (AF1029) was from R & D Systems. H2-Kb
SIINFEKL tetramer was purchased from MBL International.
DC preparation
To harvest DCs from lymphoid tissue, organs were minced
and digested with 250 µg/ml collagenase B (Roche) and 30
U/ml DNase I (Sigma-Aldrich) for 30–60 min at 37°C with
stirring in 5 ml complete IMDM + 10% FCS (cIMDM).
Erythrocytes (RBCs) were removed using ACK lysis buffer
(150 mM ammonium chloride, 10 mM potassium bicarbonate, and 0.1 mM EDTA). Cells were passed through a 70-µm
nylon mesh and counted with a Vi-CELL analyzer (Beckman
Coulter). For FACS analysis, 5–10 × 106 cells were stained in
MACS buffer. Before sorting, DCs were first enriched using
CD11c microbeads (Miltenyi Biotec).
For peripheral tissue DCs, organs were digested in collagenase D (Roche) and DNase I (Sigma-Aldrich) for 1 h at 37°C
with stirring in 5 ml cIMDM. Liver cells were separated using
a Percoll gradient (Sigma-Aldrich). Small intestine suspensions
were prepared as described previously (Satpathy et al., 2013).
BM culture with FLT3L
BM was flushed from mouse tibias and femurs, and RBCs
were removed using ACK lysis buffer. BM cells were cultured at 2 × 106 cells/ml in cIMDM containing 100
ng/ml FLT3L for 8–10 d. Loosely adherent cells were
harvested for analysis.
moDC preparation
To obtain BM monocytes, femurs, tibias, and hip bones were
crushed using a mortar and pestle in MACS buffer. After passage through a 70-µm strainer, BM cells were isolated by gradient centrifugation using Histopaque 1119 (Sigma-Aldrich).
Before sorting, B cells were depleted using B220 microbeads
(Miltenyi Biotec). Up to one million sorted monocytes were
cultured in 3 ml cIMDM with 20 ng/ml GM-CSF with or
without 20 ng/ml IL-4 (PeproTech) for 4 d. Loosely adherent
cells were obtained for analysis.
Cell sorting
Spleen DCs were sorted as B220−MHCII+CD11c+CD24+CD172− (CD8α+) and B220−MHCII+CD11c+
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The linearized vector was electroporated into EDJ22
ES cells (129SvEv background), and targeted clones were
identified by Southern analysis with the 5′ probe and confirmed with the 3′ probe. Probes were amplified from genomic DNA using the following primers: RAB43_5P_F,
5′-GCCGATGTCCTCAGATCAAT-3′; RAB43_5P_R, 5′GTAGAGCCCTCGCTCCTTCT-3′; RAB43_3P_F, 5′GAAACAGGTTGGAGCCCATA-3′; and RAB43_3P_R,
5′-TGACTTGGAAAAGCCCATTC-3′.
Blastocyst injections were performed to generate
male chimeras. Germline Rab43+/fl mice were crossed to
129S6-Tg(Prnp-GFP/Cre)1Blwd mice for constitutive
germline deletion (RAB43Δ/Δ 129). Germline Rab43+/f
were also crossed to B6.129S4-Gt(ROSA)26Sortm1(FLP1)
Dym
/JRainJ (FLPeR) to delete the neomycin cassette, generating the Rab43fl allele. Rab43+/fl mice were backcrossed
10 generations to the C57BL/6J background (stock no.
029844). Rab43+/fl were either bred to B6.C-Tg(CMV-cre)1Cgn/J to generate Rab43Δ/Δ B6 mice (stock
no. 029845) or bred to B6.Cg-Tg(Itgax-cre)1-1Reiz/J
(CD11c-cre) mice from The Jackson Laboratory to generate conditional deletion of Rab43.
Genotyping PCR was conducted to confirm germline
transmission and to confirm neo deletion from the FLPeR
mouse. The primers used were the following: 5′-CACTGC
CCAGTCTAGCTTCC-3′, 5′-GAGTGGCTCTCCCCT
TAACC-3′, and 5′-GGGTGGGGTGGGATTAGATA-3′.
To screen for the presence of the orphan loxP or constitutive
deletion, we used the following primers: 5′-AGGCAGAAG
CAAGCAGGTTT-3′, 5′-GTGATCTGGGCCAAAACG
TA-3′, and 5′-CAAAGCTATCCGACCAGGAC-3′.
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CD24−CD172+ (CD8α−) DCs. Populations from BM were
sorted as Lin− CD117intCD135+CD115+CD11c−MHCII−
(CDP), B220+CD317+SiglecH+ (pDC), or MHCII−CD11c−
SiglecH−B220−c-kit−Ly6G−M-CSFR+CD11b+Ly6chi (BM
monocytes). Other populations were sorted from spleens as
auto+ F4/80+ (macrophages), CD90.2+CD8+ (CD8 T cells),
CD90.2+CD4+ (CD4T cells),or B220+ (B cells).OT-1 cells were
sorted as B220−CD4−CD11c−CD45.1+CD8+Vα2+. OT-II
cells were sorted as B220−CD4+CD11c−CD45.1+CD8−Vα2+.

Antigen presentation assays
The in vivo cross-presentation assay has been previously described (den Haan et al., 2000). In brief, for both in vivo and
in vitro cross-presentation assays, MHCI TKO splenocytes
were osmotically loaded with 10 mg/ml OVA (Worthington Biochemical Corporation), irradiated at 1,350 rad, and
injected i.v. at the indicated doses. After 8 d, the spleens from
the mice were harvested and analyzed for tetramer+ T cells.
For in vitro cell-associated antigen cross-presentation
assays by moDCs, 25,000 CFSE-labeled OT-1 T cells were
plated with 25,000 moDCs from WT or Rab43Δ/Δ 129 mice
and various doses of MHCI TKO PBS- or OVA-loaded and
irradiated splenocytes in cIMDM in a 96-well plate. After incubating for 3 d in a 37°C and 8% CO2 incubator, CD45.1
OT-1 T cells were analyzed by FACS analysis for CFSE dilution and up-regulation of CD44.
HKLM-OVA (a gift from H. Shen, University of Pennsylvania, Philadelphia, PA) was grown in Brain-Heart Infusion
broth at 37°C for 6 h and then frozen overnight after dilution
plating for titer enumeration. Then, bacteria was thawed and
washed three times with DPBS before heat killing at 80°C for
1 h and frozen at −80°C. 10,000 DCs from WT or Rab43Δ/Δ
B6 mice were incubated with various doses of HKLM-OVA
and 25,000 CFSE-labeled OT-1 T cells for 3 d in a 37°C
5% CO2 incubator and assayed for CFSE dilution and CD44
expression of OT-1 cells. Soluble OVA and peptide presentation assays used 10,000 DCs and 25,000 CFSE-labeled OT-1
T cells for 3 d. In peptide presentation assays, DCs were incubated with SIINFEKL for 45 min and then washed with
cIMDM before incubation with 25,000 OT-1 T cells. Class
II presentation assays were performed with 10,000 DCs incubated with OVA-loaded irradiated splenocytes and sorted
OT-II T cells for 3 d and then analyzed for OT-II prolifer2880

Generation of RAB43 monoclonal antibody
For immunization, we used Rab43−/− mice that were generated
from Rab43tm1(KOMP)Wtsi ES cells (Knockout Mouse Project).
Genotyping primers for Rab43−/− mice were: 5′-GCCATC
ACGAGATTTCGATT-3′,
5′-TCCCTTCCTACACAG
CATCC-3′, and 5′-CCTGGCTGAGCACTATGACA3′. Rab43−/− mice were immunized with KLH-conjugated
RAB43 peptide, KLH-CIMRHGGPMFSEKNTDHIQLD
SKDIA (Genscript). Sera and hybridoma supernatants were
screened by ELISA using recombinant His-tagged RAB43
produced as follows: Rab43 was amplified from cDNA using
the primers RAB43 Nde1 F (5′-ATTAAGATCTATGGC
GGGCCCTGGCC-3′) and RAB43 Xho1 R (5′-ATTACT
CGAGTCAGCACCCACAGCCCCA-3′) and cloned into
the pET-28a+ vector (EMD Millipore). Recombinant protein
was purified on Ni– nitrilotriacetic acid agarose (QIAGEN).
Anti–mouse RAB43 antibody clone 2E6, an IgG1, was purified from hybridoma culture supernatant (Bio X Cell).
Intracellular staining
After staining for surface molecules, splenocytes were fixed
in 4% paraformaldehyde in DPBS for 15 min at room temperature, washed, and suspended in permeabilization buffer
(DPBS + 0.5% saponin + 2% FCS). Cells were incubated
with anti–mouse RAB43 antibody biotinylated using
NHS-dPEG4-Biotin (G-Biosciences) for 30–60 min at 4°C,
washed with DPBS buffer containing + 0.05% saponin + 2%
FCS, and incubated with streptavidin-FITC (BD).
Confocal microscopy
DCs from FLT3L-cultured BM were added to 24-well plates
containing Alcian blue (Electron Microscopy Sciences)–
coated coverslips at 500,000 cells/well in cIMDM either
alone or with 1 µg/ml LPS (Sigma-Aldrich) and allowed
to adhere for 3–4 h at 37°C and 8% CO2. Cells were fixed
in 4% paraformaldehyde (Electron Microscopy Sciences)
in DPBS for 15 min at room temperature, quenched with
0.4 M glycine in DPBS, washed, and incubated with BlockAid (Invitrogen) in 0.2% saponin. Cells were stained with
primary antibody in 2% FCS and 0.2% saponin in DPBS
overnight at 4°C. After washing 3 × 5 min in DPBS with
0.2% saponin, cells were stained with secondary antibody in
2% FCS and 0.2% saponin in DPBS for 1–2 h at 4°C. Cells
were washed and mounted in ProLong Gold Antifade with
DAPI (Invitrogen) and allowed to cure overnight at room
temperature before imaging. FLT3L-cultured DCs were imaged using a confocal microscope (LSM-510; ZEISS) with
a 63× oil immersion objective and analyzed using ImageJ
(National Institutes of Health).
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In vitro TLR stimulation
2 × 105 FLT3L-cultured BM cells were plated into 96-well
plates and stimulated with the following TLR agonists: 1 µg/
ml LPS from Escherichia coli (055:B5; Sigma-Aldrich), 50
µg/ml polyI:C (Sigma-Aldrich), 63 nM ODN1826, class
B CpG oligonugleotide (CpG; InvivoGen), and 2.5 µg/ml
STAg (prepared as previously described; Subauste, 2012).
Cells were allowed to incubate at 37°C and 8% CO2 for 1 h,
and then, 1 µg/ml brefeldin A was added for an additional 4 h.
Cells were then washed and prepared for surface and intracellular cytokine staining.

ation. Direct presentation assays were performed by sorting
DCs and performing hypertonic loading with soluble OVA
protein (Worthington Biochemical Corporation). After loading, 10,000 DCs were plated with 25,000 OT-1 cells for 3 d
and then analyzed for OT-1 proliferation.
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Western analysis
Isolated cells were washed in DPBS and resuspended in radioimmunoprecipitation assay lysis buffer with protease inhibitors at 107 cells/ml. Whole-cell extracts were obtained
and denatured in Laemmli sample buffer at 95°C for 5 min.
For glycosylation analysis, 2–3 × 106 cell equivalents of
protein lysate were incubated with either EndoH Hf (New
England Biolabs, Inc.) or PNGaseF (New England Biolabs,
Inc.) for 1 h at 37°C as per the manufacturer’s protocol
before Western analysis. 1 × 105–2.5 × 105 cell equivalents
of whole-cell extract were run on a polyacrylamide gel and
transferred onto a nitrocellulose membrane. Immunoblots
were blocked in DPBS containing 3% BSA and 0.1% Tween
20 at room temperature for 1 h and then incubated with
primary antibody overnight at 4°C. After extensive washing, membranes were incubated with goat anti–rabbit IgG
(H + L) or goat anti–mouse IgG (H + L) conjugated to
horseradish peroxidase (Jackson ImmunoResearch Laboratories, Inc.) for 1 h at room temperature in 5% nonfat milk
and 0.1% Tween 20 DPBS. Then, membranes were washed
and developed with ECL Plus Western Blotting substrate
(Thermo Fisher Scientific). Membranes were stripped using
37.5 mM Tris-HCl, pH 6.8, 1% SDS, and 0.1 M β-mercaptoethanol at 60°C for 30 min.
Quantitative RT-PCR
Cells were processed using an RNeasy Mini kit (QIAGEN)
and Superscript III reverse transcription (Invitrogen) following the manufacturer’s protocol to obtain RNA and
subsequent cDNA. A StepOnePlus Real-Time PCR system (Applied Biosystems) was used according to the manufacturer’s instructions with the Quantitation-Standard
Curve method and HotStart-IT SYBR green quantitaJEM Vol. 213, No. 13

tive PCR master mix (Affymetrix). PCR conditions were
95°C for 10 min, followed by 40 two-step cycles of 95°C
for 15 s and 60°C for 1 min. The primers used for measurement of RAB43 were as follows: RAB43 quantitative
PCR forward, 5′-ACTGGATCGAGGATGTGAGG-3′;
and reverse, 5′-ACATTGCTGGAGTCCTTTGC-3′. Hprt
primers were as follows: HPRT quantitative PCR forward,
5′-TCAGTCAACGGGGGACATAAA-3′; and reverse,
5′-GGGGCTGTACTGCTTAACCAG-3′.
Microarray analysis
Microarray data previously generated in our laboratory (GEO
accession nos. GSE53312 and GSE37030; Satpathy et al.,
2012; Kc et al., 2014) or by the Immgen Consortium (GEO
accession no. GSE15907; Heng et al., 2008) were analyzed.
Gene array data were processed using robust multiarray average quantile normalization, and data were modeled using
ArrayStar software (DNASTAR).
Statistics
Statistical analyses were performed with Prism (GraphPad
Software). Two-way ANOVA with multiple comparisons was
performed for statistical significance.
Online supplemental material
Fig. S1 shows a sequence alignment between human and
mouse RAB43. Fig. S2 is the targeting strategy used to generate Rab43Δ/Δ and Rab43cKO mice. Video 1 shows a rotating Z stack of a WT CD8α+ DC stained with RAB43,
giantin, and DAPI after uptake of labeled HKLM-OVA.
Video 2 shows a rotating Z stack of a Rab43Δ/Δ CD8α+
DC stained with RAB43, giantin, and DAPI after uptake of labeled HKLM-OVA.
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Labeled HKLM-OVA was prepared by labeling 3 ×
109 bacteria with 100 µl Alexa Fluor 647 succinimidyl ester
(Thermo Fisher Scientific) for 1 h while vortexing. Then,
bacteria were washed three times in PBS with reducing concentrations of BSA. HKLM-OVA was added to cells during
attachment, and staining was performed as described in
the previous paragraph.
Sorted Ly6G−CD90.2−B220−DX5−Ly6c−F4/80−CD11c+
splenocytes were plated at 100,000–300,000 cells/well in
cIMDM onto anti-MHCII–coated coverslips in 24-well plates.
After centrifuging at 1,000 rpm for 3 min, cells were allowed to
adhere for 30–60 min at 37°C and 8% CO2, surface stained, and
then fixed and stained similar to the FLT3L DCs.
Images of splenocytes and images after HKLM-OVA
internalization were acquired on a confocal microscope
(A1Rsi; Nikon) with a 60× oil immersion objective and analyzed using ImageJ. Colocalization analysis was performed
using ImarisColoc. In brief, fluorescence was masked on a
cell-by-cell basis for organelle stain, and percentage of Rab43
staining within that area was recorded. Golgi area was determined using ImageJ region of interest area calculations.
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Figure S1. Sequence alignment of RAB43. (A) Sequence alignment for mouse RAB43 (mRAB43) and human RAB43 (hRAB43). Conserved sequence (*),
conservative mutation (:), semiconservative mutation (.), and nonconservative mutation () are shown.

Figure S2. Targeting strategy for Rab43cKO. Shown are the Rab43 genomic locus, targeting vector, and mutated allele before removal of the neomycin
cassette (pGK-Neo). Exons are displayed as boxes with coding regions shaded. An orphan LoxP sequence was inserted at the AccI site (A). Correctly targeted
alleles show a 5.3-kB band detected by the 5′ probe and a 10-kB band detected by the 3′ probe. Chr., chromosome; DTA, diphtheria toxin A expression
cassette; TK, thymidine kinase promoter. triangles, LoxP sequences; ovals, FRT sequences.
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Video 1. Localization of RAB43 after HKLM-OVA internalization. Rotating Z stack of sorted SiglecH−CD11b−Sirpa−Bst2− cells
from FLT3 cultures of WT B6 BM were incubated with Alexa Fluor 647–labeled HKLM-OVA (white) and were allowed to attach
to coverslips, fixed, and stained for giantin (red) and RAB43 (green). Coverslips were attached to slides using ProLong Gold antifade with DAPI (blue).

Video 2. HKLM-OVA localization in RAB43-deficient DCs. Rotating Z stack of sorted SiglecH−CD11b−Sirpa−Bst2− cells from
FLT3 cultures of Rab43Δ/Δ B6 BM were incubated with Alexa Fluor 647–labeled HKLM-OVA (white) and were allowed to attach
to coverslips, fixed, and stained for giantin (red) and RAB43 (green). Coverslips were attached to slides using ProLong Gold antifade with DAPI (blue).
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